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Long-term consequences of low birth weight
LEONARDO REYES and REYNALDO MAN˜ALICH
Instituto de Nefrologı´a, Habana, Cuba
Long-term consequences of low birth weight. There is accu-
mulating evidence of the impact of low birth weight in adult
age. Thus, the Barker theory and Brenner hypothesis gain more
power. This article reviews and analyzes the evidence that sup-
ports the intrauterine origin of chronic noncommunicable dis-
eases in adult age, particularly systemic arterial hypertension
and chronic renal insufficiency. These are possibly related to
lower nephron numbers, acquired in utero or later in life, which
can increase susceptibility to kidney damage from diseases such
as hypertension and diabetes mellitus, or cause arterial hyper-
tension and secondary renal damage.
Resumen
Cada dı´a es ma´s evidente el impacto que tiene el bajo peso
al nacer en la vida adulta. De aquı´ que la teorı´a de Barker y la
hipo´tesis de Brenner cobren ma´s fuerza. El presente reporte re-
visa y analiza la evidencia a favor del origen intrauterino de en-
fermedades cro´nicas no transmisibles del adulto, especialmente
la hipertensio´n arterial siste´mica y la insuficiencia renal cro´nica.
Estas u´ltimas se relacionan probablemente con un nu´mero bajo
de nefronas, adquirido en la etapa intrauterina o en forma pos-
terior, lo cual incrementa la susceptibilidad al dan˜o renal en
enfermedades como la hipertensio´n y la diabetes mellitus, o
bien, el causar hipertensio´n arterial y dan˜o renal secundario.
INTRODUCTION
Studies in the 1980s relating low birth weight (LBW) to
chronic noncommunicable diseases in adult age allowed
the formulation of Barker’s hypothesis of the intrauterine
origin of diseases suffered in adult age. Through time, this
hypothesis has gained enough evidence that it is practi-
cally regarded as a theory today. This hypothesis has been
enriched by others, such as Brenner’s hypothesis [1], in
more specific areas like systemic arterial hypertension
(AHT) and chronic kidney disease (CKD), which has
confirmed that LBW constitutes a risk factor for some
diseases in adult age. The Brenner hypothesis also con-
tinues to gain increasing evidence and seems poised to
become a theory in the near future.
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THE BARKER THEORY AND THE BRENNER
HYPOTHESIS
These 2 concepts strongly complement one another.
Barker’s theory establishes a framework for the fetal ori-
gin of adult-age diseases. This theory is based on epi-
demiologic associations between fetal malnutrition due
to different causes expressed by LBW in infancy and pre-
mature morbidity/mortality in adult age. The first asso-
ciation found was between LBW and AHT [2]. Other
associations of LBW, such as ischemic cardiomyopathy
[3] and stroke [4], were described later, followed by asso-
ciations with glucose intolerance or type II diabetes melli-
tus (DM) [5], chronic obstructive respiratory disease [6],
and syndrome X, which is essentially a combination of
metabolic abnormalities, including type II DM, AHT [7],
dyslipidemia, obesity, and high levels of corticosteroids
[8–10]. But it was not until the studies from Brenner’s
group that Barker’s theory was directly applied to AHT
and renal diseases [11]. The reduced number of nephrons
that accompany LBW can cause AHT or increase renal
vulnerability to external agents predisposing subsequent
AHT, thus facilitating the initiation and progression of
CKD [12, 13].
In response to criticisms of the epidemiologic studies
that support this hypothesis, this article will respond to
some questions in reference to LBW and its relation to the
development and evolution of noncommunicable CKD
in adult age.
WHAT IS LBW?
Identifying, by their weight at birth, those newborns
with restrictions in fetal growth is difficult, due to multi-
ple factors that intervene in intrauterine growth. Never-
theless, a definition is necessary to unify statistics in the
study of clinical epidemiology.
Mamelle et al studied the intrauterine growth poten-
tial in 72,000 births according to anthropometric mea-
surements of the mother (age and height), calculated the
lowest weight that should be considered a restriction in
fetal growth, and identified a group of normal children
(classified as constitutionally small) that could be wrongly
classified on the basis of their gestational age [14]. More-
over, it is known that nephrogenesis ends at 36 weeks,
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and Irving et al demonstrated that premature children,
independent of birth weight, have risk factors for cardio-
vascular disease in adult age, thus making it very difficult
to separate the effects of gestational age and birth weight
[15]. However, the growth retardation for a given gesta-
tional age has greater relevance than the effect of prema-
turity on subsequent cardiovascular disease in adult age,
as was demonstrated by Whincup et al [16]. Therefore, for
a better interpretation of earlier studies and more recent
ones, a limit of 2.5 kg is maintained to classify any given
case as “restricted intrauterine growth” independent of
gestational age (preterm or in term).
WHAT ARE THE CAUSES OF LBW?
The supply of nutrients to the human fetus and its
environment are the main influences that regulate fetal
growth. Fetal growth depends on a series of long and
vulnerable steps known as the fetal supply line, which in-
cludes the composition and height of the maternal body,
its storage of nutrients, alimentary habits during preg-
nancy, transport of nutrients to and through the placenta,
arrival of toxins to the placenta and the fetus, and other
factors. The final consequence of the alteration of any of
these steps is fetal-growth restriction.
In experimental models, the main causes of LBW are:
protein malnutrition, vitamin A deficiency, antibiotics
administration: aminoglycosides, beta-lactam, corticos-
teroid administration, insulin resistance, genetics.
In humans, the causes of LBW are multifactorial—
sociodemographic factors: adolescent pregnancy, mater-
nal weight below 50 kg, family dysfunction, malnutri-
tion, especially during pregnancy; maternal gestational
weight gain below 7 kg; chronic infections; AHT during
pregnancy; LBW of the mother; glucose intolerance or
DM during pregnancy; smoking; alcohol abuse; genetics;
other.
WHAT ARE THE EFFECTS OF LBW AT THE
RENAL LEVEL?
Animal studies
Studies of LBW in laboratory animals and the very
few histomorphometric studies in humans provide con-
flicting answers to this question. Merlet-Benichou et al
proposed a model of congenital oligonephropathy in rats
provoking retardation in intrauterine growth by ligature
of the uterine artery on day 17 of gestation. Weight at
birth was significantly reduced, as well as the number of
nephrons [17]. Schwedler et al found that intrauterine ex-
posure to gentamycin in rats genetically predisposed to
glomerular sclerosis produces a reduction in the number
of nephrons and worsening of the glomerulosclerosis, as
well as a reduction of birth weight, but this does not hap-
pen in animals not genetically predisposed to sclerosis
[18]. Nathanson et al demonstrated that in vitro and in
utero exposure to beta-lactam antibiotics in rats prevents
nephrogenesis. They found a direct correlation between
nephron reduction in exposed rats and their weight at
birth [19]. Jones et al reported that animal models that
produce a LBW use extreme situations such as a pro-
nounced low-protein diet, administration of nephrotoxic
agents, or ligature of a uterine artery, which produces
models with a high fetal or neonatal mortality and lim-
ited applicability to clinical situations more frequently
encountered in humans [20].
Vitamin A (retinol) and its main derivative, retinoic
acid, are also involved in nephrogenesis, and rats exhibit a
dose-dependent effect of vitamin A on nephron number.
A mild vitamin A deficit during pregnancy could lead to
a nephron deficit in the offspring that enhances the risk
of kidney disease [21]. Human data on this relationship
are not available.
In humans, nephrogenesis is completed before birth, at
36 weeks of pregnancy, but in rats it is completed 7 or 8
days after birth. Thus, postpartum nephrogenesis is very
important to determine the final number of nephrons in
the rat. If the protein restriction in rats is not very severe,
a reduction in the number of nephrons is not observed in
spite of LBW.
Human studies
Leroy et al examined the kidneys of children who died
of nonrenal causes in neonatal intensive care units. Chil-
dren with weight under the 10th percentile were com-
pared with children with weight values above that fig-
ure of the same gestational age. In those with low weight
for this classification, the kidneys weighed less and had
fewer nephrons [22]. Hinchliffe et al found that children
with retarded intrauterine growth had fewer nephrons
but the same glomerular volume [23], and Man˜alich et al
found that children with a weight at birth below 2.5 kg
had fewer nephrons and larger glomerular volume than
children with higher birth weights. They observed a mean
reduction of 20% of the nephrons in children with LBW
[24].
More recently, other studies support these findings.
Hughson et al have shown that weight at birth is a strong
determinant of the number of nephrons and glomerular
size, which confirms that LBW is accompanied by fewer
large-volume nephrons than in individuals with normal
birth weights [25]. Hoy et al, in a study of autopsies,
demonstrated that corpuscular volume is inversely pro-
portionate to the number of glomeruli [26]. In an indi-
rect manner, by ultrasonographic renal measurements,
this histologic birth-weight relation has been supported.
Deutinger et al compared ultrasonographic quantitative
measurements of renal growth with measurements of re-
nal function and indicated the feasibility of an evaluation
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of the functional limitations of the intrauterine urinary
system [27]. Finally, Spencer et al demonstrated that the
renal volume of individuals with LBW is lower than that
of individuals with normal birth weight [28].
WHAT ARE THE CLINICAL CONSEQUENCES
OF LBW?
The short-term consequences of LBW can be summa-
rized as having up to 12 times higher perinatal mortal-
ity [29] and 3 times higher morbidity than that observed
for a birth weight appropriate to gestational age [30]. A
growing number of studies suggest that exposure to an ab-
normal intrauterine environment affects anthropometric,
metabolic, and mental development, leading to increased
risk of disease later in life.
Law et al reviewed 43 different studies since 1956, in-
cluding 66,000 patients between 0 and 71 years of age
and found a good correlation between birth weight and
systolic and diastolic arterial pressure [31]. Nilsson et al
analyzed blood pressure and LBW in 149,378 Swedish
children and found a significant relation between birth
weight and systolic arterial pressure. An increase of 1 kg
of weight at birth was associated with a 0.8-mm Hg re-
duction in systolic pressure [32]. Likewise, Huxley et al
reviewed the relation between systolic arterial pressure,
birth weight, and postnatal growth. They analyzed 80 rel-
evant articles published between March 1996 and March
2000, encompassing more than 440,000 individuals from 0
to 84 years of age of all races. Arterial pressure was noted
to be approximately 2 mm Hg lower for each kg increase
in weight at birth, and accelerated postnatal growth in
LBW children was strongly associated with higher blood
pressure levels [33].
New histomorphometric evidence in humans pro-
vided by Keller et al confirmed that fewer large-volume
glomeruli are found in patients with primary AHT than
in normotensive patients [34]. However, there are other
clinical situations where nephron number is lower, yet
AHT is either nonexistent or infrequent [35]. In to-
tal, more than 38 studies from different countries have
demonstrated that people with LBW are likely to have
higher arterial pressure in childhood and in adult age.
IMPACT OF LOW NEPHRON NUMBER
In the 1970s, the Laboratory of Kidney Electrolytes and
Physiology, directed by Barry Brenner and the Depart-
ment of Pathology of the Brigham and Women’s Hos-
pital, developed methods of renal micropuncture and
mathematical models that allowed them to quantify the
determinants of glomerular filtration. As a result, they
showed that increased capillary pressure and glomerular
flow were important contributors to glomerular damage,
especially in models of kidney ablation [36–38]. Thus,
the “glomerular hyperfiltration” theory emerged. The
concept of glomerular hyperfiltration and hypertension
in remnant nephrons as an adverse effect of the re-
duction in nephronal mass, and its association with sys-
temic AHT, represents a critical stage in advancing the
field of nephrology. Subsequent studies of intervention
with protein restriction and inhibitors of the angiotensin-
converting enzyme reinforced increased capillary pres-
sure as the primary cause of glomerular damage [38, 39].
Lastly, the finding that renal damage was autoperpetu-
ated in models of reduced nephron number was an im-
portant foundation for future studies of the progression
of kidney disease [36].
INCREASE IN RENAL VULNERABILITY
There is evidence that the oligonephronia associated
with LBW increases renal vulnerability or worsens the
evolution of renal diseases in these individuals. Ross-
ing et al reported a high risk of diabetic nephropathy
among patients with type I DM and LBW [40], and later,
Nelson et al reported the same risk among patients with
type II DM [41]. Duncan et al indicated that LBW with
reduced nephron number has an unfavorable influence in
patients with membranous glomerulopathy [42]. Yudkin
et al reported the presence of proteinuria and progres-
sive renal disease in elderly patients without diabetes that
had been of LBW [43]. Zidar et al indicated the unfavor-
able clinical course of nephrotic syndrome with minimal
glomerular changes in children with LBW, as well as the
more intense changes of glomerulosclerosis seen in the
renal biopsies of children with glomerulopathy caused
by immunoglobulin A and LBW [44, 45]. More recently,
Sheu et al confirmed the unfavorable evolution and treat-
ment response of nephrotic syndrome caused by minimal
glomerular changes in children with LBW [46].
PROGRESSION OF RENAL INSUFFICIENCY
The partial ablation of renal mass, in combination with
the congenital deficit of nephron number in individuals
of LBW, may initiate a cycle of progressive glomerular
damage accompanied by glomerular hypertrophy, intra-
glomerular hypertension, and systemic AHT. Response
to decreased renal mass in humans varies according
to age at loss, underlying condition, and extent of tis-
sue loss. Several follow-up studies performed on renal
donors, as well as patients nephrectomized secondary to
trauma and unilateral diseases, suggest a relatively benign
course after unilateral nephrectomy [47, 48]. By contrast,
patients with nephrectomy for bilateral disease, more ex-
tensive loss of renal mass (bilateral tumors) [49], unilat-
eral nephrectomy at a younger age [50], and unilateral
renal agenesis [51] show a surprisingly high incidence of
glomerular sclerosis, proteinuria, hypertension, and renal
insufficiency.
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Likewise, the number of viable nephrons of the donor
kidney can determine the long-term prognosis of renal
function of the graft. This is because renal ischemia,
reperfusion, and acute rejection reduce the number of
nephrons, and predispose the transplanted kidney to
AHT and glomerulosclerosis, as has been shown in ex-
perimental studies [52, 53]. Chertow et al, in a study of
survival in 31,515 kidney transplants performed in the
United States between 1987 and 1991, demonstrated,
with multiple regression analysis, that the risk of los-
ing renal function increased when the donor kidney had
fewer nephrons (as occurs in donors of advanced age,
women, and African Americans) and when the recipient
had a large body surface area [54]. These findings support
the existence of antigen-independent factors that are as-
sociated with renal failure, and are consistent with the
progression of renal damage that may occur in oligone-
phronia due to LBW.
CHRONIC KIDNEY DISEASE
There is a real epidemic of CKD among the Aborig-
ines in Australia’s Northern Territory, with an incidence
between 1994 and 1996 of 2700 per million inhabitants
that doubles every 4 years, being 20 times greater than
in the non-Aboriginal population [12]. The association
between LBW and CKD may be related to an impedi-
ment of nephrogenesis caused by intrauterine malnutri-
tion and/or an adverse intrauterine environment, as has
been shown in various studies [17, 22–24]. The frequency
of LBW is more than double in the Aboriginal popula-
tion, and the epidemic of CKD might be explained by the
protein malnutrition and vitamin A deficit that provoked
high mortality rates among children of LBW in recent
decades [12]. However, other factors such as intrauterine
stress or environmental exposures cannot be excluded
[55, 56].
In recent years, a high incidence of CKD has been
noted in the southeast United States. The incidence of
terminal CKD is 345 per million inhabitants compared
with 269 per million in the rest of the country. In South
Carolina, the incidence of CKD doubled between 1987
and 1996, with AHT and DM as the main causes (71% of
all patients). Additionally, a significant correlation was
found between weight at birth and CKD in this study.
LBW was more common in South Carolina than in other
states and is more common among African Americans
than Caucasians. The risk of CKD with AHT is 5 times
greater in African Americans. There is a significant corre-
lation of LBW and CKD among both African Americans
and Caucasians, but LBW is twice as common among the
former [13].
On the basis of this review, we conclude that LBW and
associated prenatal AHT are important precursors to an
increased vulnerability to renal disease in adult age.
FUTURE DIRECTIONS
Interventions through programs geared to adolescents,
as well as prenatal attention, will contribute to improve
the indicators of neonatal development, particularly ges-
tational age, intrauterine growth rate, and birth weight.
In high biologic, psychologic, and social risk groups, it
is especially important to eliminate or attenuate delete-
rious intrauterine exposures/stresses and to monitor the
mother’s nutritional and health status before and during
pregnancy. Such an approach will help promote normal
fetal growth rates and birth weights, and reduce the inci-
dence of premature births and subsequent exacerbation
of increased incidence and severity of many diseases, in-
cluding CKD, in adulthood.
Reprint requests to Leonardo Reyes, M.D., Instituto de Nefrologia,
Ave. 26 y Boyeros, Plaza, Apdo. 6358, Habana 10600, Cuba.
E-mail: lreyes@infomed.sld.cu
REFERENCES
1. BRENNER BM, GARCIA DL, ANDERSON S: Glomeruli and blood pres-
sure. Less of one, more of the other? Am J Hypertens 1:335–347,
1988
2. WADSWORTH MEJ, CRIPPS HA, MIDWINTER RE, et al: Blood pressure
in a national birth cohort at the age of 36 related to social and familial
factors, smoking, and body mass. BMJ 291:1534–1538, 1985
3. BARKER DJP, OSMOND C: Infant mortality, childhood nutrition, and
ischaemic heart disease in England and Wales. Lancet 1:1077–1081,
1986
4. BARKER DPJ, OSMOND C: Deaths rates from stroke in England and
Wales predicted from post-maternal mortality. BMJ 295:83–86, 1987
5. HALES CN, BARKER DPJ, CLARK PMS, et al: Fetal and infant growth
and impaired glucose tolerance at age 64 years. BMJ 303:1019–1022,
1991
6. BARKER DPJ, GODFREY KM, FALL C, et al: Relation of birth weight
and childhood respiratory infection to adult lung function and
death from chronic obstructive airway disease. BMJ 303:671–675,
1991
7. BARKER DPJ, HALES CN, FALL CHD, et al: Type 2 (non–insulin-
dependent) diabetes mellitus, hypertension and hyperlipidaemia
(Syndrome X): Relation to reduced fetal growth. Diabetologia
36:62–67, 1993
8. BENEDIKTSSON R, LINDSAY RC, NOBLE J, et al: Glucocorticoid expo-
sure in utero: New model for adult hypertension. Lancet 341:339–
341, 1993
9. JOHANNES CB, STELLATO RK, FELDMAN HA, et al: Relation of de-
hydroepiandrosterone and dehydroepiandrosterone sulphate with
cardiovascular disease risk factors in women: Longitudinal results
from the Massachusetts Women’s Health Study. J Clin Epidemiol
52:95–103, 1999
10. PHILLIPS DI, WALKER BL, REYNOLDS RM, et al: LBW predicts ele-
vated plasma cortisol concentrations in adults from 3 populations.
Hypertension 35:1301–1306, 2000
11. BRENNER BM, CHERTOW GM: Congenital oligonephropathy and the
etiology of adult hypertension and progressive renal injury. Am J
Kidney Dis 23:171–175, 1994
12. HOY WE, REES M, KILE E, et al: A new dimension to the Barker hy-
pothesis: Low birthweight and susceptibility to renal disease. Kidney
Int 56:1072–1077, 1999
13. LACKLAND DT, BENDALL HE, OSMOND C, et al: LBWs contribute to
high rates of early-onset chronic renal failure in the Southeastern
United States. Arch Intern Med 160:1472–1476
14. MAMELLE N, COCHET V, CLARIS O: Definition of fetal growth re-
striction according to constitutional growth potential. Biol Neonate
80:277–285, 2001
15. IRVING RJ, BELTON NR, ELTON RA, et al: Adult cardiovascular risk
factors in premature babies. Lancet 355:2135–2136, 2000
Reyes and Man˜alich: Long-term consequences of LBW S-111
16. WHINCUP PH, COOK DG, PAPACOSTA O: Do maternal and intrauter-
ine risk factors influence blood pressure in childhood? Arch Dis
Child 67:1423–1429, 1992
17. MERLET-BENICHOU C, GILBERT T, MUFFAT-JOLY M, et al: Intrauterine
growth retardation leads to a permanent nephron deficit in the rat.
Pediatr Nephrol 8:175–180, 1994
18. SCHWEDLER SB, GILBERT T, MOREAU E, et al: Nephrotoxin expo-
sure in uterus reduces glomerular number in sclerosis-prone but
not sclerosis-resistant mice. Kidney Int 56:1683–1690, 1999
19. NATHANSON S, MOREAU E, MERLET-BENICHOU C, et al: In utero and
vitro exposure to beta-lactams impair kidney development in the
rat. J Am Soc Nephrol 11:874–884, 2000
20. JONES SE, NYENGAARD JR, FLYVBJERG A, et al: Birth weight has
no influence on glomerular number and volume. Pediatr Nephrol
16:340–345, 2001
21. MERLET-BENICHOU C: Influence of fetal environment on kidney de-
velopment. Int J Dev Biol 43:453–456, 1999
22. LEROY B, JOSSET P, MORGAN G, et al: Intrauterine growth retarda-
tion (IUGR) and nephron deficit: Preliminary study in man. Pediatr
Nephrol 6:C21, 1992
23. HINCHLIFFE SA, LYNCH MR, SARGENT PH, et al: The effect of
intrauterine growth retardation on the development of renal
nephrons. BJOG 99:296–301, 1992
24. MAN˜ALICH R, REYES L, HERRERA M, et al: Relationship between
weight at birth and number and size of renal glomeruli in humans:
A histomorphometric study. Kidney Int 58:770–773, 2000
25. HUGHSON M, FARRIS AB III, DOUGLAS-DENTON R, et al: Glomeru-
lar number and size in autopsy kidneys: The relationship to birth
weight. Kidney Int 63:2113–2122, 2003
26. HOY WE, DOUGLAS-DENTON RN, HUGHSON MD, et al: A stereolog-
ical study of glomerular number and volume: Preliminary findings
in a multiracial study of kidney at autopsy. Kidney Int 63(Suppl
83):S31–S37, 2003
27. DEUTINGER J, BARTL W, PFERSMANN C, et al: Fetal kidney volume
and urine production in case of growth retardation. J Perinat Med
15:307–315, 1987
28. SPENCER J, WANG Z, HOY WE, et al: LBW and reduced renal volume
in Aboriginal children. Am J Kidney Dis 37:915–920, 2001
29. DAVIS JA, DOBBING J (editors): Scientific Foundations of Paediatrics,
London, Heinemann, 1974, pp 69–80
30. LIN CC: Intrauterine growth retardation. Obstet Gynecol Annu
14:127–221, 1985
31. LAW CM, SHIELL AW: Is blood pressure inversely related to birth
weight? The strength of evidence from a systematic review of the
literature. J Hypertens 14:935–941, 1996
32. NILSSON PM, OSTERGREN PO, NYBERG P, et al: LBW is associated
with elevated systolic blood pressure in adolescence: A prospective
study of birth cohort of 149,378 Swedish boys. J Hypertens 15:1627–
1631, 1997
33. HUXLEY RR, SHIELL AW, LAW CM: The role of size at birth and
postnatal catch-up growth in determining systolic blood pressure:
A systematic review of the literature. J Hypertens 18:815–831,
2000
34. KELLER G, ZIMMER G, MALL G, et al: Nephron number in patients
with primary hypertension. N Engl J Med 348:101–108, 2003
35. JOHNSON RJ, RODRı´GUEZ-ITURBE B, HERRERA-ACOSTA J, et al:
Nephron number and primary hypertension. N Engl J Med
348:1717–1719, 2003
36. OLSON JL, HOSTETTER TH, RENNKE HG, et al: Altered glomerular
permeselectivity and progressive sclerosis following extreme abla-
tion of renal mass. Kidney Int 22:112–126, 1982
37. HOSTETTER TH, OLSON JL, RENNKE HG, et al: Hyperfiltration in
remnant nephrons: A potentially adverse response to renal ablation.
J Am Soc Nephrol 12:1315–1325, 2001
38. ANDERSON S, MEYER TW, RENNKE HG, et al: Control of glomerular
hypertension limits glomerular injury in rats with reduced renal
mass. J Clin Invest 76:612–619, 1985
39. MEYER TW, ANDERSON S, RENNKE HG, et al: Reversing glomerular
hypertension stabilizes established glomerular injury. Kidney Int
31:752–759, 1987
40. ROSSING P, TARNOW L, NIELSEN FS, et al: LBW: A risk factor for
development of diabetic nephropathy? Diabetes 44:1405–1407, 1995
41. NELSON RG, MORGENSTERN H, BENNETT PH, et al: Birth weight and
renal disease in Pima Indians with type 2 diabetes mellitus. Am J
Epidemiol 148:650–656, 1998
42. DUNCAN RC, BASS PS, GARRETT PJ, et al: Weight at birth and
other factors influencing progression of idiopathic membrenous
nephropathy. Nephrol Dial Transplant 9:875, 1994
43. YUDKIN JS, PHILLIPS DI, STANNER S. Proteinuria and progressive
renal disease: Birth weight and microalbuminuria. Nephrol Dial
Transplant 12(Suppl 2):S10–S13, 1997
44. ZIDAR N, CAVIC MA, KENDA RB, et al: Unfavorable course of mini-
mal change nephrotic syndrome in children with intrauterine growth
retardation. Kidney Int 54:1320–1323, 1998
45. ZIDAR N, CAVIC MA, KENDA RB, et al: Effect of intrauterine growth
retardation on the clinical course and prognosis of IgA glomeru-
lonephritis in children. Nephron 79:28–32, 1998
46. SHEU JN, CHEN JH: Minimal change nephrotic syndrome in children
with intrauterine growth retardation. Am J Kidney Dis 37:909–914,
2001
47. FOGO A, ICHIKAWA I: Glomerular growth promoter: The common
channel to glomerular sclerosis. Semin Nephrol 4:213–225, 1990
48. FOTINO S: The solitary kidney: A model of chronic hyperfiltration in
humans. Am J Kidney Dis 13:88–98, 1989
49. NOVICK AC, GEPHARDT G, GUZ B, et al: Long-term follow-up after
partial removal of a solitary kidney. N Engl J Med 325:1058–1062,
1991
50. DI TULLIO MT, CASALE F, INDOLfi P, et al: Compensatory hypertro-
phy and progressive renal damage in children nephrectomized for
Wilms’ Tumor. Med Pediatr Oncol 26:325–328, 1996
51. ARGUESO L, RITCHEY ML, BOYLE ET, et al: Prognosis of patients
with unilateral renal agenesis. Pediatr Nephrol 6:412–416, 1992
52. HEEMANN VW, AZUMA H, TULLIUS SG, et al: The contribution of
reduced functioning mass to chronic kidney allograft dysfunction in
rats. Transplantation 58:1317–1322, 1994
53. MACKENZIE HS, TULLIUS SG, HEEMANN VW, et al: Nephron supply
is a major determinant of long-term renal allograft outcome in rats.
J Clin Invest 94:2148–2152, 1994
54. CHERTOW GM, MILFORD EL, MACKENZIE HS, et al: Antigen-
independent determinants of cadaveric kidney transplant failure.
JAMA 276:1732–1736, 1996
55. IGOSHEVA N, KLIMOVA O, ANISHCHENKO T, et al: Prenatal stress alters
cardiovascular responses in adult rats. J Physiol 557:273–285, 2004
56. MONE SM, GILLMAN MW, MILLER TL, et al: Effects of environmental
exposures on the cardiovascular system: Prenatal period through
adolescence. Pediatrics 113(Suppl 4):1058–1069, 2004
